David Wink

7PUBLICATIONS
43CO-AUTHORS
Molecular targetsPredictive and prognostic markersHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Dec 31, 2024
NOS inhibition sensitizes metaplastic breast cancer to PI3K inhibition and taxane therapy via c-JUN repression.

Tejaswini Reddy, Akshjot Puri, Liliana Guzman-Rojas

|Aug 02, 2024
TRAIL-induced cytokine production via NFKB2 pathway promotes neutrophil chemotaxis and immune suppression in triple negative breast cancers.

Manjari Kundu, Yoshimi E Greer, Alexei Lobanov

|May 11, 2023
Interferon-gamma is quintessential for NOS2 and COX2 expression in ER<sup>-</sup> breast tumors that lead to poor outcome.

Robert Y S Cheng, Lisa A Ridnour, Adelaide L Wink

|Dec 15, 2022
Targeting Nitric Oxide: Say NO to Metastasis.

Tejaswini P Reddy, Sharon A Glynn, Timothy R Billiar

|Aug 20, 2019
NO and hepatocellular cancer.

Ronghua Wang, David A Geller, David A Wink

Pageof 2